NASDAQ:BLRX
$0.640
(
-1.99%
)
Friday, 27th Jan 2023
BioLineRx Ltd. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.545 | $0.740 | Friday, 27th Jan 2023 BLRX stock ended at $0.640. This is 1.99% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 7.48% from a day low at $0.620 to a day high of $0.666. |
| 90 days | $0.545 | $0.90 | |
| 52 weeks | $0.545 | $1.98 |
Historical BioLineRx Ltd. prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.650 | $0.666 | $0.620 | $0.640 | 302 876 |
| 2023-01-26 | $0.680 | $0.684 | $0.640 | $0.653 | 165 228 |
| 2023-01-25 | $0.675 | $0.690 | $0.662 | $0.677 | 196 411 |
| 2023-01-24 | $0.672 | $0.700 | $0.667 | $0.675 | 213 990 |
| 2023-01-23 | $0.670 | $0.690 | $0.660 | $0.670 | 278 424 |
| 2023-01-20 | $0.697 | $0.700 | $0.670 | $0.678 | 169 712 |
| 2023-01-19 | $0.700 | $0.700 | $0.670 | $0.700 | 179 100 |
| 2023-01-18 | $0.729 | $0.740 | $0.700 | $0.705 | 135 616 |
| 2023-01-17 | $0.703 | $0.740 | $0.695 | $0.738 | 446 937 |
| 2023-01-13 | $0.690 | $0.710 | $0.680 | $0.690 | 153 500 |
| 2023-01-12 | $0.680 | $0.680 | $0.660 | $0.680 | 182 300 |
| 2023-01-11 | $0.687 | $0.690 | $0.680 | $0.689 | 123 022 |
| 2023-01-10 | $0.695 | $0.700 | $0.661 | $0.690 | 200 664 |
| 2023-01-09 | $0.723 | $0.725 | $0.680 | $0.698 | 300 728 |
| 2023-01-06 | $0.680 | $0.720 | $0.670 | $0.710 | 263 900 |
| 2023-01-05 | $0.677 | $0.700 | $0.660 | $0.686 | 192 373 |
| 2023-01-04 | $0.654 | $0.700 | $0.650 | $0.694 | 381 686 |
| 2023-01-03 | $0.603 | $0.690 | $0.600 | $0.650 | 960 733 |
| 2022-12-30 | $0.571 | $0.600 | $0.564 | $0.590 | 317 202 |
| 2022-12-29 | $0.550 | $0.575 | $0.545 | $0.573 | 363 877 |
| 2022-12-28 | $0.565 | $0.594 | $0.550 | $0.569 | 185 244 |
| 2022-12-27 | $0.570 | $0.585 | $0.545 | $0.566 | 318 910 |
| 2022-12-23 | $0.560 | $0.600 | $0.550 | $0.580 | 234 827 |
| 2022-12-22 | $0.590 | $0.595 | $0.550 | $0.572 | 261 907 |
| 2022-12-21 | $0.570 | $0.602 | $0.551 | $0.580 | 162 644 |
| 2022-12-20 | $0.624 | $0.624 | $0.548 | $0.590 | 1 188 460 |
| 2022-12-19 | $0.620 | $0.650 | $0.601 | $0.615 | 238 205 |
| 2022-12-16 | $0.638 | $0.660 | $0.601 | $0.644 | 233 644 |
| 2022-12-15 | $0.660 | $0.672 | $0.638 | $0.638 | 261 156 |
| 2022-12-14 | $0.640 | $0.687 | $0.638 | $0.648 | 101 479 |
| 2022-12-13 | $0.690 | $0.700 | $0.638 | $0.645 | 312 575 |
| 2022-12-12 | $0.682 | $0.700 | $0.680 | $0.690 | 113 968 |
| 2022-12-09 | $0.690 | $0.708 | $0.660 | $0.690 | 285 458 |
| 2022-12-08 | $0.670 | $0.708 | $0.654 | $0.690 | 308 854 |
| 2022-12-07 | $0.670 | $0.710 | $0.670 | $0.690 | 80 416 |
| 2022-12-06 | $0.727 | $0.727 | $0.679 | $0.680 | 281 002 |
| 2022-12-05 | $0.720 | $0.740 | $0.700 | $0.727 | 141 492 |
| 2022-12-02 | $0.695 | $0.720 | $0.676 | $0.716 | 188 955 |
| 2022-12-01 | $0.705 | $0.750 | $0.688 | $0.695 | 224 701 |
| 2022-11-30 | $0.705 | $0.720 | $0.681 | $0.705 | 312 614 |
| 2022-11-29 | $0.720 | $0.720 | $0.695 | $0.701 | 166 440 |
| 2022-11-28 | $0.700 | $0.720 | $0.689 | $0.700 | 240 424 |
| 2022-11-25 | $0.710 | $0.710 | $0.688 | $0.692 | 77 594 |
| 2022-11-23 | $0.680 | $0.700 | $0.650 | $0.690 | 188 811 |
| 2022-11-22 | $0.665 | $0.700 | $0.665 | $0.695 | 282 748 |
| 2022-11-21 | $0.660 | $0.680 | $0.650 | $0.671 | 290 925 |
| 2022-11-18 | $0.720 | $0.720 | $0.671 | $0.690 | 229 777 |
| 2022-11-17 | $0.680 | $0.680 | $0.630 | $0.672 | 347 802 |
| 2022-11-16 | $0.698 | $0.698 | $0.650 | $0.661 | 430 042 |
| 2022-11-15 | $0.710 | $0.710 | $0.650 | $0.679 | 542 703 |
About BioLineRx Ltd.
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
